⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RARE News
Ultragenyx Pharmaceutical Inc.
Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2025 Financial Results and Corporate Update
globenewswire.com
RARE
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ultragenyx Pharmaceutical
globenewswire.com
RARE
Rosen Law Firm Urges Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) Stockholders to Contact the Firm for Information About Their Rights
businesswire.com
RARE
Bronstein, Gewirtz & Grossman LLC Urges Ultragenyx Pharmaceutical Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
RARE
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Ultragenyx Pharmaceutical Inc. (RARE)
globenewswire.com
RARE
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Ultragenyx Pharmaceutical Inc. (RARE) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm
globenewswire.com
RARE
INVESTOR ALERT: Ultragenyx Pharmaceutical Inc. (RARE) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
prnewswire.com
RARE
RARE STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ultragenyx Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
RARE
INVESTOR ALERT: Ultragenyx Pharmaceutical Inc. (RARE) Investors with Substantial Losses Have Opportunity to Lead the Ultragenyx Class Action Lawsuit – RGRD Law
globenewswire.com
RARE
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Ultragenyx Pharmaceutical Inc. Securities Class Action Lawsuit
businesswire.com
RARE